Cited by 1,815Nonmelanoma Skin Cancer StudiesGlobal Cancer Incidence and ScreeningCutaneous Melanoma Detection and Management

Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012

Open access
Rogers, Howard W., Weinstock, Martin A., Feldman, Steven R., Coldiron, Brett M.·2015·JAMA Dermatology

Abstract

IMPORTANCE: Understanding skin cancer incidence is critical for planning prevention and treatment strategies and allocating medical resources. However, owing to lack of national reporting and previously nonspecific diagnosis classification, accurate measurement of the US incidence of nonmelanoma skin cancer (NMSC) has been difficult. OBJECTIVE: To estimate the incidence of NMSC (keratinocyte carcinomas) in the US population in 2012 and the incidence of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) in the 2012 Medicare fee-for-service population. DESIGN, SETTING, AND PARTICIPANTS: This study analyzes US government administrative data including the Centers for Medicare & Medicaid Services Physicians Claims databases to calculate totals of skin cancer procedures performed for Medicare beneficiaries from 2006 through 2012 and related parameters. The population-based National Ambulatory Medical Care Survey database was used to estimate NMSC-related office visits for 2012. We combined these analyses to estimate totals of new skin cancer diagnoses and affected individuals in the overall US population. MAIN OUTCOMES AND MEASURES: Incidence of NMSC in the US population in 2012 and BCC and SCC in the 2012 Medicare fee-for-service population. RESULTS: The total number of procedures for skin cancer in the Medicare fee-for-service population increased by 13% from 2,048,517 in 2006 to 2,321,058 in 2012. The age-adjusted skin cancer procedure rate per 100,000 beneficiaries increased from 6075 in 2006 to 7320 in 2012. The number of procedures in Medicare beneficiaries specific for NMSC increased by 14% from 1,918,340 in 2006 to 2,191,100 in 2012. The number of persons with at least 1 procedure for NMSC increased by 14% (from 1,177,618 to 1,336,800) from 2006 through 2012. In the 2012 Medicare fee-for-service population, the age-adjusted procedure rate for BCC and SCC were 3280 and 3278 per 100,000 beneficiaries, respectively. The ratio of BCC to SCC treated in Medicare beneficiaries was 1.0. We estimate the total number of NMSCs in the US population in 2012 at 5,434,193 and the total number of persons in the United States treated for NMSC at 3,315,554. CONCLUSIONS AND RELEVANCE: This study is a thorough nationwide estimate of the incidence of NMSC and provides evidence of continued increases in numbers of skin cancer diagnoses and affected patients in the United States. This study also demonstrates equal incidence rates for BCC and SCC in the Medicare population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamadermatol.2015.1187

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There is a clear difference in sensitivity to UV-induced neoplasia between corneal epithelial and epidermal cells.

    “Although the cornea shares functional and structural similarities with the skin, there is a clear difference in sensitivity to UV-induced neoplasia between corneal epithelial and epidermal cells.”

    From Faster DNA Repair of Ultraviolet-Induced Cyclobutane Pyrimidine Dimers and Lower Sensitivity to Apoptosis in Human Corneal Epithelial Cells than in Epidermal Keratinocytes (2016) · cites this paper as [26]

    The Discussion (page unavailable) addresses nonmelanoma skin cancer incidence and mentions chronic UV exposure, but does not compare corneal epithelial cells with epidermal cells. Searches for corneal sensitivity, UV-induced neoplasia, and a cornea–skin comparison found no passage addressing the claimed difference. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [14]14. Staples M, Marks R, Giles G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect? Int J Cancer. 1998;78(2):144-148.

Cited by

Sorted by citations

Authors
Rogers, H. W., Weinstock, M. A., Feldman, S. R., & Coldiron, B. M.
Affiliations
  • Advanced Dermatology (US)
  • Brown University (US)
  • Wake Forest University Health Sciences (US)
  • University of Cincinnati Medical Center (US)
Corresponding author
Rogers, Howard W.
Venue
JAMA Dermatology
Published
2015-10-01
Volume
151
Issue
10
Pages
1081
ISSN
2168-6068 (ISSN-L)
OpenAlex
W2040600853
Cited by
1,815
References
22
Citations by year
2026: 94 · 2025: 152 · 2024: 193 · 2023: 187 · 2022: 213 · 2021: 214 · 2020: 232 · 2019: 179 · 2018: 150 · 2017: 114 · 2016: 73 · 2015: 7 · 2014: 1 · 2012: 1
FWCI
89.97
Type
journal article
Language
en
Open access
Locations
  • JAMA Dermatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Nonmelanoma Skin Cancer Studies
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
Keywords
non-melanoma skin cancer, basal cell carcinoma, squamous cell carcinoma, skin cancer incidence, Medicare fee-for-service beneficiaries, incidence estimation, National Ambulatory Medical Care Survey, skin cancer prevention
MeSH terms
Aged, Aged, 80 and over, Basal Cell Carcinoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Female, Medicare, Humans, Male, Middle Aged, Skin Neoplasms, United States, Keratinocytes, Incidence, Databases, Factual, Health Care Surveys

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review